| Product Code: ETC7625441 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland CAR-T Cell Therapy Treatment Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland CAR-T Cell Therapy Treatment Market - Industry Life Cycle |
3.4 Ireland CAR-T Cell Therapy Treatment Market - Porter's Five Forces |
3.5 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Structure, 2021 & 2031F |
3.7 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Targeted Antigens, 2021 & 2031F |
3.8 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.9 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
4 Ireland CAR-T Cell Therapy Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Growing adoption of personalized medicine |
4.2.3 Advancements in biotechnology and immunotherapy research |
4.3 Market Restraints |
4.3.1 High treatment costs associated with CAR-T cell therapy |
4.3.2 Limited availability of specialized healthcare facilities for CAR-T cell therapy |
4.3.3 Regulatory challenges and reimbursement issues |
5 Ireland CAR-T Cell Therapy Treatment Market Trends |
6 Ireland CAR-T Cell Therapy Treatment Market, By Types |
6.1 Ireland CAR-T Cell Therapy Treatment Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Autologous CAR-T Cells, 2021- 2031F |
6.1.4 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Allogeneic CAR-T Cells, 2021- 2031F |
6.2 Ireland CAR-T Cell Therapy Treatment Market, By Structure |
6.2.1 Overview and Analysis |
6.2.2 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By First Generation CAR-T Cells, 2021- 2031F |
6.2.3 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Second Generation Car-T Cells, 2021- 2031F |
6.2.4 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Third Generation CAR-T Cells, 2021- 2031F |
6.2.5 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Fourth Generation CAR-T Cells, 2021- 2031F |
6.3 Ireland CAR-T Cell Therapy Treatment Market, By Targeted Antigens |
6.3.1 Overview and Analysis |
6.3.2 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Solid Tumors, 2021- 2031F |
6.3.3 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Hematologic Malignancies, 2021- 2031F |
6.4 Ireland CAR-T Cell Therapy Treatment Market, By Brand |
6.4.1 Overview and Analysis |
6.4.2 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Yescarta, 2021- 2031F |
6.4.3 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Kymriah, 2021- 2031F |
6.4.4 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Tecartus, 2021- 2031F |
6.5 Ireland CAR-T Cell Therapy Treatment Market, By Therapeutic Application |
6.5.1 Overview and Analysis |
6.5.2 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Hematological Malignancies, 2021- 2031F |
6.5.3 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.5.4 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.5.5 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.5.6 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Gastric Cancer, 2021- 2031F |
6.5.7 Ireland CAR-T Cell Therapy Treatment Market Revenues & Volume, By Multiple Myeloma, 2021- 2031F |
7 Ireland CAR-T Cell Therapy Treatment Market Import-Export Trade Statistics |
7.1 Ireland CAR-T Cell Therapy Treatment Market Export to Major Countries |
7.2 Ireland CAR-T Cell Therapy Treatment Market Imports from Major Countries |
8 Ireland CAR-T Cell Therapy Treatment Market Key Performance Indicators |
8.1 Number of clinical trials and research studies on CAR-T cell therapy in Ireland |
8.2 Patient satisfaction and outcomes post CAR-T cell therapy treatment |
8.3 Adoption rate of CAR-T cell therapy among healthcare providers in Ireland |
8.4 Number of partnerships and collaborations between biopharmaceutical companies and healthcare institutions for CAR-T cell therapy research and development |
9 Ireland CAR-T Cell Therapy Treatment Market - Opportunity Assessment |
9.1 Ireland CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Ireland CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Structure, 2021 & 2031F |
9.3 Ireland CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Targeted Antigens, 2021 & 2031F |
9.4 Ireland CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.5 Ireland CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
10 Ireland CAR-T Cell Therapy Treatment Market - Competitive Landscape |
10.1 Ireland CAR-T Cell Therapy Treatment Market Revenue Share, By Companies, 2024 |
10.2 Ireland CAR-T Cell Therapy Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here